Literature DB >> 23632887

ASB2α regulates migration of immature dendritic cells.

Isabelle Lamsoul1, Arnaud Métais, Emmanuelle Gouot, Mélina L Heuzé, Ana-Maria Lennon-Duménil, Christel Moog-Lutz, Pierre G Lutz.   

Abstract

The actin-binding protein filamins (FLNs) are major organizers of the actin cytoskeleton. They control the elasticity and stiffness of the actin network and provide connections with the extracellular microenvironment by anchoring transmembrane receptors to the actin filaments. Although numerous studies have revealed the importance of FLN levels, relatively little is known about the regulation of its stability in physiological relevant settings. Here, we show that the ASB2α cullin 5-ring E3 ubiquitin ligase is highly expressed in immature dendritic cells (DCs) and is down-regulated after DC maturation. We further demonstrate that FLNs are substrates of ASB2α in immature DCs and therefore are not stably expressed in these cells, whereas they exhibit high levels of expression in mature DCs. Using ASB2 conditional knockout mice, we show that ASB2α is a critical regulator of cell spreading and podosome rosette formation in immature DCs. Furthermore, we show that ASB2(-/-) immature DCs exhibit reduced matrix-degrading function leading to defective migration. Altogether, our results point to ASB2α and FLNs as newcomers in DC biology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23632887     DOI: 10.1182/blood-2012-11-466649

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Dendritic cell migration in health and disease.

Authors:  Tim Worbs; Swantje I Hammerschmidt; Reinhold Förster
Journal:  Nat Rev Immunol       Date:  2016-11-28       Impact factor: 53.106

2.  E3 ubiquitin ligases in regulating stress fiber, lamellipodium, and focal adhesion dynamics.

Authors:  Shishan Deng; Cai Huang
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

3.  ASB2α, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domain.

Authors:  Ziba Razinia; Massimiliano Baldassarre; Gaia Cantelli; David A Calderwood
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

Review 4.  Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity.

Authors:  Joseph W Dean; Liang Zhou
Journal:  Trends Immunol       Date:  2022-02-05       Impact factor: 16.687

Review 5.  The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it.

Authors:  Rosalinda M Savoy; Paramita M Ghosh
Journal:  Endocr Relat Cancer       Date:  2013-11-04       Impact factor: 5.678

6.  BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions.

Authors:  Danfeng Zhang; Jingcao Huang; Fangfang Wang; Hong Ding; Yushan Cui; Yan Yang; Juan Xu; Hongmei Luo; Yuhan Gao; Ling Pan; Yu Wu; Yuping Gong; Liping Xie; Zhigang Liu; Ying Qu; Li Zhang; Weiping Liu; Wenyan Zhang; Sha Zhao; Qing Yi; Ting Niu; Yuhuan Zheng
Journal:  Cell Death Dis       Date:  2021-05-15       Impact factor: 8.469

7.  Small Wonders-The Use of Nanoparticles for Delivering Antigen.

Authors:  Aya Taki; Peter Smooker
Journal:  Vaccines (Basel)       Date:  2015-08-10

8.  The notch pathway promotes NF-κB activation through Asb2 in T cell acute lymphoblastic leukemia cells.

Authors:  Wei Wu; Li Nie; Li Zhang; Yan Li
Journal:  Cell Mol Biol Lett       Date:  2018-08-09       Impact factor: 5.787

9.  Substrates of the ASB2α E3 ubiquitin ligase in dendritic cells.

Authors:  Camille A Spinner; Sandrine Uttenweiler-Joseph; Arnaud Metais; Alexandre Stella; Odile Burlet-Schiltz; Christel Moog-Lutz; Isabelle Lamsoul; Pierre G Lutz
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

Review 10.  Trial watch: Dendritic cell-based interventions for cancer therapy.

Authors:  Erika Vacchelli; Ilio Vitale; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fučíková; Isabelle Cremer; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-07-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.